ETF Managers Group LLC raised its position in shares of Cooper Companies Inc (NYSE:COO) by 15.3% during the 4th quarter, HoldingsChannel reports. The fund owned 565 shares of the medical device company’s stock after acquiring an additional 75 shares during the period. ETF Managers Group LLC’s holdings in Cooper Companies were worth $144,000 as of its most recent SEC filing.
Other institutional investors have also recently bought and sold shares of the company. Essex Savings Bank purchased a new stake in Cooper Companies during the 4th quarter valued at $25,000. Focused Wealth Management Inc purchased a new stake in Cooper Companies during the 4th quarter valued at $127,000. CENTRAL TRUST Co raised its stake in Cooper Companies by 17.1% during the 4th quarter. CENTRAL TRUST Co now owns 513 shares of the medical device company’s stock valued at $131,000 after buying an additional 75 shares during the last quarter. Resources Management Corp CT ADV purchased a new stake in Cooper Companies during the 3rd quarter valued at $203,000. Finally, Engineers Gate Manager LP purchased a new stake in Cooper Companies during the 3rd quarter valued at $208,000.
NYSE:COO opened at $276.07 on Monday. The company has a quick ratio of 1.16, a current ratio of 2.03 and a debt-to-equity ratio of 0.60. The firm has a market capitalization of $13.62 billion, a PE ratio of 23.96, a P/E/G ratio of 2.17 and a beta of 0.88. Cooper Companies Inc has a one year low of $216.47 and a one year high of $288.51.
Cooper Companies (NYSE:COO) last posted its quarterly earnings data on Thursday, December 6th. The medical device company reported $2.87 EPS for the quarter, missing the consensus estimate of $2.96 by ($0.09). The company had revenue of $651.50 million during the quarter, compared to analysts’ expectations of $645.25 million. Cooper Companies had a return on equity of 17.70% and a net margin of 5.52%. The company’s revenue for the quarter was up 16.0% on a year-over-year basis. During the same quarter last year, the company earned $2.65 earnings per share. Sell-side analysts expect that Cooper Companies Inc will post 11.54 EPS for the current fiscal year.
The business also recently disclosed a semiannual dividend, which was paid on Friday, February 8th. Stockholders of record on Tuesday, January 22nd were paid a $0.03 dividend. The ex-dividend date was Friday, January 18th. This represents a dividend yield of 0.02%. Cooper Companies’s dividend payout ratio (DPR) is 0.52%.
COO has been the subject of a number of research reports. Wells Fargo & Co boosted their target price on shares of Cooper Companies from $290.00 to $295.00 and gave the company an “outperform” rating in a research note on Monday, November 12th. Zacks Investment Research reiterated a “hold” rating and set a $285.00 target price on shares of Cooper Companies in a research note on Monday, November 12th. KeyCorp decreased their target price on shares of Cooper Companies from $298.00 to $296.00 and set an “overweight” rating for the company in a research note on Friday, December 7th. BMO Capital Markets boosted their target price on shares of Cooper Companies from $294.00 to $306.00 and gave the company an “outperform” rating in a research note on Friday, December 7th. Finally, Jefferies Financial Group boosted their target price on shares of Cooper Companies to $305.00 and gave the company a “buy” rating in a research note on Friday, December 7th. Two research analysts have rated the stock with a sell rating, one has issued a hold rating and eight have issued a buy rating to the company’s stock. Cooper Companies currently has an average rating of “Buy” and a consensus target price of $289.44.
In related news, Director Allan E. Rubenstein acquired 348 shares of Cooper Companies stock in a transaction dated Monday, December 10th. The stock was purchased at an average cost of $241.59 per share, for a total transaction of $84,073.32. Following the purchase, the director now directly owns 4,524 shares of the company’s stock, valued at approximately $1,092,953.16. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 1.70% of the company’s stock.
Cooper Companies Profile
The Cooper Companies, Inc operates as a medical device company worldwide. It operates through CooperVision and CooperSurgical business units. The company develops, manufactures, and markets a range of contact lenses, including spherical lenses, and toric and multifocal lenses that correct near- and farsightedness, as well as addresses various complex visual defects, such as astigmatism and presbyopia.
Featured Article: No Load Funds
Want to see what other hedge funds are holding COO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cooper Companies Inc (NYSE:COO).